Abstract: This cleaning flow path comprises: a case; and an escape prevention unit for preventing a cleaning agent accommodated in a dry state inside the case from escaping outside the case. The case includes: a body part that has an accommodation space for accommodating the cleaning agent therein; a water inlet passage that provides a flow path for water to flow into the accommodation space, is open toward the outside of the case, and can be installed into the water purifier by being connected to a first fastening hole in the water purifier connected to a raw water inlet port of a filter; and a water outlet passage that provides a flow path for the water accommodated in the accommodation space to flow out of the case, can be installed into the water purifier by being connected to a second fastening hole in the water purifier connected to a purified water outlet port of the filter, and is open in the same direction as the water inlet passage.

Abstract: Provided is a substrate processing apparatus, more particularly, a substrate processing apparatus capable of suppressing an generation of process by-products in a substrate processing process. A substrate processing apparatus includes a chamber part configured to provide an inner space in which a substrate is processed, a gas supply part configured to supply a process gas to the inner space, a substrate support configured to support the substrate, a heating liner provided inside the chamber part to at least partially surround the inner space, and a heating part configured to heat the heating liner.

Abstract: An image sensing device comprising, a latch array including, a first latch group, a second latch group, a first latch controller generates a first latch control signal to control the first latch group, and a second latch controller generates a second latch control signal to control the second latch group, wherein a second edge of the second latch control signal occurs after a first edge of the first latch control signal.

Abstract: Disclosed is a method of controlling at least one server configured to assign a task to a plurality of robots assisting to a worker. The control method includes generating one or more picking rounds including a plurality of orders with respect to the same shipment, identifying at least one robot corresponding to an idle state as a target robot, selecting a picking round with the highest priority among the one or more picking rounds in progress, assigning the target robot to the selected picking round, selecting a location group matching a picking unit in a waiting state among a plurality of location groups in which locations at which shipments related to the selected picking round are stored are grouped, and assigning the target robot to the selected location group and assigning a picking task to the target robot according to a picking unit matching the selected location group.

Abstract: The present invention discloses a back contact solar cell. The back contact solar cell includes a semiconductor substrate having a front surface and a rear surface; a first conductive type semiconductor region having a first conductive type and a second conductive type semiconductor region having a second conductive type at an interval on the rear surface of the semiconductor substrate. Furthermore, the rear surface of the semiconductor substrate has a texturing structure at the interval between the first conductive type semiconductor region and the second conductive type semiconductor region.

Abstract: A seat adjustment apparatus for a vehicle includes a plurality of connection frames provided along two opposite sides of a seat frame and two opposite sides of a back frame and configured to move forward or rearward depending on a folding direction of the back frame, guide parts provided at middle points of the plurality of connection frames and configured to be moved upward or downward by forward or rearward movements of the connection frames, and a seat cushion pipe provided inside the two connection frames and configured such that front ends of the seat cushion pipe are connected to the guide parts, and a position of a rear end of the seat cushion pipe is adjusted upward or downward by upward or downward movements of the guide parts.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.